| ARVO Home | Mobile Version | Print-Friendly Version | Send to a Friend |
Feb. 22, 2017




 

 

Manage ARVO e-News
Search Back Issues

In This Issue
Events & education
Imaging conference abstract submission deadline extended
New online training modules: Research essentials
Everything ARVO
Will new human research policies affect you?
ARVO Foundation
Clayton to present keynote address at WEAVR Luncheon
Researchers from developing countries receive travel awards
International Chapter Affiliate updates
What's happening across the globe?
ARVO journals
IOVS
JOV
TVST
ARVOJobs
Who's hiring?
Grants
Funding opportunities
ARVO journals
IOVS

A call for papers for a special issue in IOVS, Biomarkers and surrogate endpoints in ophthalmic clinical research, is open through March 1.

The issue will include invited papers covering glaucoma, dry eye, retinal diseases and omics, along with regulatory perspectives.

Submitted manuscripts should be original hypothesis-driven research, meta-analyses and reviews focused on the use of biomarkers and surrogate endpoints in ophthalmic clinical research and care, with particular attention to scientific advances (proposal of new biomarkers), biomarkers validation and identification. Included biomarkers might be biochemical, molecular (omics), clinical (including patient reported, symptoms, function and objective signs) and imaging.

Special guest editors for this issue are ARVO members Edoardo Villani, MD, University of Milan and Stela Vujosevic, MD, PhD, University of Padua, who organized a successful Special Interest Group Session on this topic at the 2016 ARVO Annual Meeting.

Submit your manuscript by the March 1 deadline. For additional information, email iovs@arvo.org.

top of page up arrow Back to Contents Page Previous Article | Next Article
Association for Research in Vision and Ophthalmology
1801 Rockville Pike, Suite 400 | Rockville MD 20852-5622
tel: +1.240.221.2900 | fax: +1.240.221.0370 | arvo@arvo.org | www.arvo.org
You are receiving ARVO Insight as a member service or because of your involvement with ARVO.

View ARVO's Privacy Policy.

To ensure delivery of Insight, please add arvo@arvo.org to your e-mail address book or Safe Sender List.
If you are still having problems receiving our communications, get more information about white-listing.